SHINE Medical says it will produce 70% of global demand for medical isotope moly-99

SHINE Medical Technologies proposed production facility in the Netherlands. Rendering courtesy of SHINE Medical Technologies.
SHINE Medical Technologies says it will produce 70% of the global patient need for molybdenum-99, a diagnostic isotope used in nuclear medicine. The Janesville-based company is building a production facility for molybdenum-99 or moly-99 in…

Want to Read More?

Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In

Or click here to purchase a paywall bypass link for this article.

Get our email updates

Brandon covers startups, technology, manufacturing. He previously worked as a general assignment and court reporter for The Freeman in Waukesha. Brandon graduated from UW-Milwaukee’s journalism, advertising and media studies program with an emphasis in journalism. He enjoys live music, playing guitar and loves to hacky sack.

No posts to display